MORGAN WEAVER: Open Payments
NPI 1427889005 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 42 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $147 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $437 |
| Amgen Inc. | 9 | $165 |
| GlaxoSmithKline, LLC. | 4 | $96 |
| ABBVIE INC. | 3 | $64 |
| Edwards Lifesciences Corporation | 1 | $60 |
| Lilly USA, LLC | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Indivior Inc. | 1 | $34 |
| Novo Nordisk Inc | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, REPATHA, BREZTRI, EVENITY, SAPIEN 3 Ultra RESILIA, QULIPTA, SUBLOCADE.
Industry payments across AZ — which companies pay providers there.
